Prospective study of neoadjuvant chemotherapy for HER2 positive breast cancer.
Not Applicable
- Conditions
- HER2 positive breast cancer
- Registration Number
- JPRN-UMIN000046338
- Lead Sponsor
- Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with active other cancers required to treat. 2) Patients with heart function failure (EF<60%). 3) Patients determined as being an inappropriate case by the investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method